The possible role of Helicobacter pylori infection in non-alcoholic fatty liver disease

Frontiers in Microbiology

Volumn 8, Issue MAY, 2017, Pages

  Cheng, Dan Dan ^a   He, Cong ^a   Ai, Hong Hui ^b   Huang, Ying ^a   Lu, Nong Hua ^a  

^a NANCHANG UNIVERSITY   (China)

^b The Yugan County People's Hospital   (China)

Author keywords

Gut microbiota; H. pylori; Insulin resistance; Lipid profile; NAFLD

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CYTOKINE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CHRONIC GASTRITIS; DYSBIOSIS; ECHOGRAPHY; FIBROSIS; GENE EXPRESSION; HELICOBACTER INFECTION; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INFLAMMATION; INSULIN CLEARANCE; INSULIN RESISTANCE; INTESTINE FLORA; LIPID ANALYSIS; LIPOLYSIS; LIVER BIOPSY; LIVER CELL; LIVER HISTOLOGY; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENICITY; PEPTIC ULCER; PREVALENCE; SHORT SURVEY; STOMACH CANCER;

EID: 85019754995     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00743     Document Type: Short Survey

References (79)

1. Abenavoli, L., Milic, N., Masarone, M., and Persico, M. (2013). Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. Med. Hypotheses 81, 913-915. doi: 10.1016/j.mehy.2013.08.011
2. Aviles-Jimenez, F., Guitron, A., Segura-Lopez, F., Mendez-Tenorio, A., Iwai, S., Hernandez-Guerrero, A., et al. (2016). Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma. Clin. Microbiol. Infect. 22, 178.e11-178.e22. doi: 10.1016/j.cmi.2015.10.008
3. Aydemir, S., Bayraktaroglu, T., Sert, M., Sokmen, C., Atmaca, H., Mungan, G., et al. (2005). The effect of Helicobacter pylori on insulin resistance. Dig. Dis. Sci. 50, 2090-2093. doi: 10.1007/s10620-005-3012-z
4. Baeg, M. K., Yoon, S. K., Ko, S. H., Noh, Y. S., Lee, I. S., and Choi, M. G. (2016). Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. World J. Gastroenterol. 22, 2592-2600. doi: 10.3748/wjg.v22.i8.2592
5. Bhala, N., Jouness, R. I., and Bugianesi, E. (2013). Epidemiology and natural history of patients with NAFLD. Curr. Pharm. Des. 19, 5169-5176. doi: 10.2174/13816128113199990336
6. Birkenfeld, A. L., and Shulman, G. I. (2014). Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59, 713-723. doi: 10.1002/hep.26672
7. Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo-Perez, F., et al. (2016). The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63, 764-775. doi: 10.1002/hep.28356
8. Buzzetti, E., Pinzani, M., and Tsochatzis, E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038-1048. doi: 10.1016/j.metabol.2015.12.012
9. Caldwell, S., and Argo, C. (2010). The natural history of non-alcoholic fatty liver disease. Dig. Dis. 28, 162-168. doi: 10.1159/000282081
10. Castera, L., Pedeboscq, A., Rocha, M., Le Bail, B., Asencio, C., De Ledinghen, V., et al. (2006). Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study. World J. Gastroenterol 12, 7278-7284. doi: 10.3748/wjg.v12.i45.7278
11. Chen, L. W., Chien, C. Y., Yang, K. J., Kuo, S. F., Chen, C. H., and Chien, R. N. (2015). Helicobacter pylori infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: a community-based study. PLoS ONE 10:e0128671. doi: 10.1371/journal.pone.0128671
12. Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Fung, C., et al. (2002). Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 36, 403-409. doi: 10.1053/jhep.2002.34738
13. Cindoruk, M., Cirak, M. Y., Unal, S., Karakan, T., Erkan, G., Engin, D., et al. (2008). Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases. Eur. J. Gastroenterol. Hepatol. 20, 33-36. doi: 10.1097/MEG.0b013e3282efa4f2
14. Dandona, P., Aljada, A., and Bandyopadhyay, A. (2004). Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7. doi: 10.1016/j.it.2003.10.013
15. Day, C. P., and James, O. F. (1998). Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845. doi: 10.1016/S0016-5085(98)70599-2
16. De Magalhaes Queiroz, D. M., and Santos, A. (2001). Isolation of a Helicobacter strain from the human liver. Gastroenterology 121, 1023-1024. doi: 10.1053/gast.2001.28574
17. Ding, X., Saxena, N. K., Lin, S., Xu, A., Srinivasan, S., and Anania, F. A. (2005). The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am. J. Pathol. 166, 1655-1669. doi: 10.1016/S0002-9440(10)62476-5
18. Dogan, Z., Filik, L., Ergul, B., Sarikaya, M., and Akbal, E. (2013). Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study. Eur. J. Gastroenterol. Hepatol. 25, 107-110. doi: 10.1097/MEG.0b013e3283590c10
19. Dogan, Z., Sarikaya, M., Ergul, B., and Filik, L. (2015). The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 159, 242-245. doi: 10.5507/bp.2014.036
20. Ford, A. C., and Axon, A. T. (2010). Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 15(Suppl. 1), 1-6. doi: 10.1111/j.1523-5378.2010.00779.x
21. Friedman, S. L. (2008). Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172. doi: 10.1152/physrev.00013.2007
22. Fukuda, Y., Bamba, H., Okui, M., Tamura, K., Tanida, N., Satomi, M., et al. (2001). Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion 63(Suppl. 1), 93-96. doi: 10.1159/000051918
23. Gen, R., Demir, M., and Ataseven, H. (2010). Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med. J. 103, 190-196. doi: 10.1097/SMJ.0b013e3181cf373f
24. Gunji, T., Matsuhashi, N., Sato, H., Fujibayashi, K., Okumura, M., Sasabe, N., et al. (2009). Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14, 144-150. doi: 10.1111/j.1523-5378.2009.00705.x
25. Heimesaat, M. M., Fischer, A., Plickert, R., Wiedemann, T., Loddenkemper, C., Gobel, U. B., et al. (2014). Helicobacter pylori induced gastric immunopathology is associated with distinct microbiota changes in the large intestines of long-term infected Mongolian gerbils. PLoS ONE 9:e100362. doi: 10.1371/journal.pone.0100362
26. Hemmasi, G., Zamani, F., Khonsari, M., Sohrabi, M., Abdollahi, N., and Ajdarkosh, H. (2013). Association between Helicobacter pylori and serum leptin in iranian dyspeptic patients. Middle East J. Dig. Dis. 5, 158-162.
27. Hennige, A. M., Stefan, N., Kapp, K., Lehmann, R., Weigert, C., Beck, A., et al. (2006). Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J. 20, 1206-1208. doi: 10.1096/fj.05-4635fje
28. Hossain, I. A., Akter, S., Bhuiyan, F. R., Shah, M. R., Rahman, M. K., and Ali, L. (2016). Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease. BMC Res. Notes 9:266. doi: 10.1186/s13104-016-2071-x
29. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271, 665-668. doi: 10.1126/science.271.5249.665
30. Huang, Y., Tian, X. F., Fan, X. G., Fu, C. Y., and Zhu, C. (2009). The pathological effect of Helicobacter pylori infection on liver tissues in mice. Clin. Microbiol. Infect. 15, 843-849. doi: 10.1111/j.1469-0691.2009.02719.x
31. Jamali, R., Mofid, A., Vahedi, H., Farzaneh, R., and Dowlatshahi, S. (2013). The effect of Helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. Hepat. Mon. 13:e14679. doi: 10.5812/hepatmon.14679
32. Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., et al. (2015). Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep. 5:8096. doi: 10.1038/srep08096
33. Keane, K. N., Cruzat, V. F., Carlessi, R., De Bittencourt, P. I. Jr., and Newsholme, P. (2015). Molecular events linking oxidative stress and inflammation to insulin resistance and beta-cell dysfunction. Oxid. Med. Cell. Longev. 2015:181643. doi: 10.1155/2015/181643
34. Khosravi, Y., Seow, S. W., Amoyo, A. A., Chiow, K. H., Tan, T. L., Wong, W. Y., et al. (2015). Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice. Sci. Rep. 5:8731. doi: 10.1038/srep08731
35. Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S., and Yki-Jarvinen, H. (2008). Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135, 122-130. doi: 10.1053/j.gastro.2008.03.021
36. Kotronen, A., Vehkavaara, S., Seppala-Lindroos, A., Bergholm, R., and Yki-Jarvinen, H. (2007). Effect of liver fat on insulin clearance. Am. J. Physiol. Endocrinol. Metab. 293, E1709-E1715. doi: 10.1152/ajpendo.00444.2007
37. Kountouras, J., Polyzos, S. A., Zavos, C., Deretzi, G., Kountouras, C., Vardaka, E., et al. (2014). Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors. Hepatology 60, 1450-1451. doi: 10.1002/hep.27168
38. La Cava, A., and Matarese, G. (2004). The weight of leptin in immunity. Nat. Rev. Immunol. 4, 371-379. doi: 10.1038/nri1350
39. Laurila, A., Bloigu, A., Nayha, S., Hassi, J., Leinonen, M., and Saikku, P. (1999). Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142, 207-210. doi: 10.1016/S0021-9150(98)00194-4
40. Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., et al. (2013). Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62, 1787-1794. doi: 10.1136/gutjnl-2012-303816
41. Leung, C., Rivera, L., Furness, J. B., and Angus, P. W. (2016). The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412-425. doi: 10.1038/nrgastro.2016.85
42. Li, L., He, Q., Huang, X., Man, Y., Zhou, Y., Wang, S., et al. (2010). NOX3-derived reactive oxygen species promote TNF-alpha-induced reductions in hepatocyte glycogen levels via a JNK pathway. FEBS Lett. 584, 995-1000. doi: 10.1016/j.febslet.2010.01.044
43. Liu, Q., Bengmark, S., and Qu, S. (2010). The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 9:42. doi: 10.1186/1476-511X-9-42
44. Maleki, I., Rastgar, A., Hosseini, V., Taghvaei, T., Rafiei, A., Barzin, M., et al. (2014). High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease. Eur. Rev. Med. Pharmacol. Sci. 18, 1583-1590.
45. Mandeville, K. L., Krabshuis, J., Ladep, N. G., Mulder, C. J., Quigley, E. M., and Khan, S. A. (2009). Gastroenterology in developing countries: issues and advances. World J. Gastroenterol. 15, 2839-2854. doi: 10.3748/wjg.15.2839
46. Marshall, B., and Warren, J. (1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1, 1273-1275.
47. Masarone, M., Federico, A., Abenavoli, L., Loguercio, C., and Persico, M. (2014). Non alcoholic fatty liver: epidemiology and natural history. Rev. Recent Clin. Trials 9, 126-133. doi: 10.2174/1574887109666141216111143
48. Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., et al. (2013). Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58, 120-127. doi: 10.1002/hep.26319
49. Myllyluoma, E., Ahlroos, T., Veijola, L., Rautelin, H., Tynkkynen, S., and Korpela, R. (2007). Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int. J. Antimicrob. Agents 29, 66-72. doi: 10.1016/j.ijantimicag.2006.08.034
50. Nam, S. Y., Ryu, K. H., Park, B. J., and Park, S. (2015). Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter 20, 125-132. doi: 10.1111/hel.12182
51. Nasif, W. A., Mukhtar, M. H., Nour Eldein, M. M., and Ashgar, S. S. (2016). Oxidative DNA damage and oxidized low density lipoprotein in Type II diabetes mellitus among patients with Helicobacter pylori infection. Diabetol. Metab. Syndr. 8:34. doi: 10.1186/s13098-016-0149-1
52. Neuschwander-Tetri, B. A., and Caldwell, S. H. (2003). Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37, 1202-1219. doi: 10.1053/jhep.2003.50193
53. Nishi, Y., Isomoto, H., Uotani, S., Wen, C. Y., Shikuwa, S., Ohnita, K., et al. (2005). Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J. Gastroenterol. 11, 695-699. doi: 10.3748/wjg.v11.i5.695
54. Okushin, K., Takahashi, Y., Yamamichi, N., Shimamoto, T., Enooku, K., Fujinaga, H., et al. (2015). Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol. 15:25. doi: 10.1186/s12876-015-0247-9
55. Oresic, M., Hyotylainen, T., Kotronen, A., Gopalacharyulu, P., Nygren, H., Arola, J., et al. (2013). Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 56, 2266-2274. doi: 10.1007/s00125-013-2981-2
56. Pellicano, R., Menard, A., Rizzetto, M., and Megraud, F. (2008). Helicobacter species and liver diseases: association or causation? Lancet Infect. Dis. 8, 254-260. doi: 10.1016/S1473-3099(08)70066-5
57. Peverill, W., Powell, L. W., and Skoien, R. (2014). Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int. J. Mol. Sci. 15, 8591-8638. doi: 10.3390/ijms15058591
58. Pirouz, T., Zounubi, L., Keivani, H., Rakhshani, N., and Hormazdi, M. (2009). Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method. Dig. Dis. Sci. 54, 1456-1459. doi: 10.1007/s10620-008-0522-5
59. Polyzos, S. A., Aronis, K. N., Kountouras, J., Raptis, D. D., Vasiloglou, M. F., and Mantzoros, C. S. (2016). Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia 59, 30-43. doi: 10.1007/s00125-015-3769-3
60. Polyzos, S. A., Kountouras, J., Papatheodorou, A., Patsiaoura, K., Katsiki, E., Zafeiriadou, E., et al. (2013a). Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 62, 121-126. doi: 10.1016/j.metabol.2012.06.007
61. Polyzos, S. A., Kountouras, J., Zavos, C., and Deretzi, G. (2011). The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 16, 79-88. doi: 10.1111/j.1523-5378.2011.00822.x
62. Polyzos, S. A., Kountouras, J., Zavos, C., and Deretzi, G. (2013b). Helicobacter pylori Infection and insulin resistance. Helicobacter 18, 165-166. doi: 10.1111/hel.12019
63. Polyzos, S. A., Nikolopoulos, P., Stogianni, A., Romiopoulos, I., Katsinelos, P., and Kountouras, J. (2014). Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study. Arq. Gastroenterol. 51, 261-268. doi: 10.1590/S0004-28032014000300017
64. Shoelson, S. E., Lee, J., and Goldfine, A. B. (2006). Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801. doi: 10.1172/JCI29069
65. Silha, J. V., Nyomba, B. L., Leslie, W. D., and Murphy, L. J. (2007). Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care 30, 286-291. doi: 10.2337/dc06-1073
66. Sumida, Y., Kanemasa, K., Imai, S., Mori, K., Tanaka, S., Shimokobe, H., et al. (2015). Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J. Gastroenterol. 50, 996-1004. doi: 10.1007/s00535-015-1039-2
67. Takaki, A., Kawai, D., and Yamamoto, K. (2013). Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int. J. Mol. Sci. 14, 20704-20728. doi: 10.3390/ijms141020704
68. Takuma, Y. (2011). Helicobacter pylori infection and liver diseases. Gan To Kagaku Ryoho 38, 362-364.
69. Tiniakos, D. G. (2010). Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. Eur. J. Gastroenterol. Hepatol. 22, 643-650. doi: 10.1097/MEG.0b013e32832ca0cb
70. Tiwari, S. K., Khan, A. A., Ibrahim, M., Habeeb, M. A., and Habibullah, C. M. (2006). Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J. Gastroenterol. 12, 2181-2186. doi: 10.3748/wjg.v12.i14.2181
71. Tsai, C. C., Kuo, T. Y., Hong, Z. W., Yeh, Y. C., Shih, K. S., Du, S. Y., et al. (2015). Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells. Virulence 6, 755-765. doi: 10.1080/21505594.2015.1043505
72. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031. doi: 10.1038/nature05414
73. Upala, S., Jaruvongvanich, V., Riangwiwat, T., Jaruvongvanich, S., and Sanguankeo, A. (2016). Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis. J. Dig. Dis. 17, 433-440. doi: 10.1111/1751-2980.12367
74. Vergun, O., and Reynolds, I. J. (2005). Distinct characteristics of Ca(2+)-induced depolarization of isolated brain and liver mitochondria. Biochim. Biophys. Acta 1709, 127-137. doi: 10.1016/j.bbabio.2005.07.006
75. Wang, Y., Li, Y. Y., Nie, Y. Q., Zhou, Y. J., Cao, C. Y., and Xu, L. (2013). Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Exp. Ther. Med. 6, 77-84. doi: 10.3892/etm.2013.1090
76. Wong, F., Rayner-Hartley, E., and Byrne, M. F. (2014). Extraintestinal manifestations of Helicobacter pylori: a concise review. World J. Gastroenterol. 20, 11950-11961. doi: 10.3748/wjg.v20.i34.11950
77. Yildirim, Z., Bozkurt, B., Ozol, D., Armutcu, F., Akgedik, R., Karamanli, H., et al. (2016). Increased exhaled 8-isoprostane and interleukin-6 in patients with Helicobacter pylori infection. Helicobacter. 21, 389-394. doi: 10.1111/hel.12302
78. Zhang, C., Guo, L., Qin, Y., and Li, G. (2016). Correlation between Helicobacter pylori infection and polymorphism of adiponectin gene promoter-11391G/A, superoxide dismutase gene innonalcoholic fatty liver disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban 41, 359-366. doi: 10.11817/j.issn.1672-7347.2016.04.004
79. Zhou, X., Liu, W., Gu, M., Zhou, H., and Zhang, G. (2015). Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway. J. Gastroenterol. 50, 1027-1040. doi: 10.1007/s00535-015-1051-6